News & Events

QuantaMatrix signed new distribution partnership with Neo-Science for the UAE market

QuantaMatrix signs distribution partnership in the UAE with NeoScience: 

"We are delighted to announce that we have signed an exclusive distribution partnership with NeoScience for the territory of the United Arab Emirates, says Stéphane Rougale, VP - Sales, Marketing & Customer Support EMEA. The UAE is a significant market in the Middle East region. We are looking forward to expanding access of dRAST to UAE Healthcare institutions thanks to the expertise and connections of NeoScience." 

Nadia Abu Hijleh, CEO of NeoScience, adds: "We are happy to partner with QuantaMatrix. The dRAST system is a perfect match with the MALDI-TOF rapid identification that we carry as well. The UAE market is definitely ready for innovative rapid AST solutions such as dRAST to help clinicians provide better healthcare to patients with bacteremia."

Awarded winner of Sepsis tender from the Great Orchestra of Christmas Charity – WOŚP in Poland!
dRAST solution receives European CE Marking IVDR
CEO Interview
QuantaMatrix Newly Listed in KOSDAQ
QuantaMatrix Held an EMEA Sales & Marketing Meeting